BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8585400)

  • 21. Treatment of hypothyroidism.
    Hueston WJ
    Am Fam Physician; 2001 Nov; 64(10):1717-24. PubMed ID: 11759078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal daily levothyroxine dose in primary hypothyroidism. Its relation to pretreatment thyroid hormone indexes.
    Kabadi UM
    Arch Intern Med; 1989 Oct; 149(10):2209-12. PubMed ID: 2508585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
    Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L).
    Fatourechi V; Lankarani M; Schryver PG; Vanness DJ; Long KH; Klee GG
    Mayo Clin Proc; 2003 May; 78(5):554-60. PubMed ID: 12744541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
    Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
    Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients.
    Ain KB; Pucino F; Shiver TM; Banks SM
    Thyroid; 1993; 3(2):81-5. PubMed ID: 8369656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologic markers in blood reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism.
    Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B
    Exp Clin Endocrinol; 1992; 99(3):129-33. PubMed ID: 1526260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic blood markers reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism.
    Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B
    Acta Med Hung; 1991; 48(1-2):33-43. PubMed ID: 1813856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy?
    Tigas S; Idiculla J; Beckett G; Toft A
    Thyroid; 2000 Dec; 10(12):1107-11. PubMed ID: 11201857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy.
    Flynn RW; Bonellie SR; Jung RT; MacDonald TM; Morris AD; Leese GP
    J Clin Endocrinol Metab; 2010 Jan; 95(1):186-93. PubMed ID: 19906785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
    Jonklaas J; Davidson B; Bhagat S; Soldin SJ
    JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism.
    Fisher DA; Schoen EJ; La Franchi S; Mandel SH; Nelson JC; Carlton EI; Goshi JH
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2722-7. PubMed ID: 10946871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difficulties in diagnosing and managing coexisting primary hypothyroidism and resistance to thyroid hormone.
    Tran HA
    Endocr Pract; 2006; 12(3):288-93. PubMed ID: 16772202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of L-thyroxine replacement.
    Burnett JR; Cooke R; Crooke MJ; Feek CM
    N Z Med J; 1992 Mar; 105(930):105-6. PubMed ID: 1553113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twice-weekly dosing for thyroxine replacement in elderly patients with primary hypothyroidism.
    Taylor J; Williams BO; Frater J; Stott DJ; Connell J
    J Int Med Res; 1994; 22(5):273-7. PubMed ID: 7867872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial partial peripheral and pituitary resistance to thyroid hormone: a frequently missed diagnosis?
    Hopwood NJ; Saunder SE; Shapiro B; Sisson JC
    Pediatrics; 1986 Dec; 78(6):1114-22. PubMed ID: 3097618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levothyroxine replacement therapy after thyroid surgery.
    Verhaert N; Vander Poorten V; Delaere P; Bex M; Debruyne F
    B-ENT; 2006; 2(3):129-33. PubMed ID: 17067083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid vascular conductance: differential effects of elevated plasma thyrotropin (TSH) induced by treatment with thioamides or TSH-releasing hormone.
    Connors JM; Huffman LJ; Michalkiewicz M; Chang BS; Dey RD; Hedge GA
    Endocrinology; 1991 Jul; 129(1):117-25. PubMed ID: 1905224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.